FFCP PHASE1:Hg19::chr13:49078858..49078865,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=strong | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr13:49078858..49078865,- | |||
|coexpression_cluster_id=C121 | |||
|description=CAGE_peak_at_chr13:49078858..49078865,- | |||
|id=chr13:49078858..49078865,- | |||
|ontology_enrichment_celltype=CL:0002127!4.72e-17!1;CL:0000914!4.72e-17!1;CL:0000911!4.72e-17!1;CL:0000814!4.72e-17!1;CL:0002042!4.72e-17!1;CL:0002039!4.72e-17!1;CL:0002040!4.72e-17!1;CL:0002041!4.72e-17!1;CL:0000893!3.43e-09!2;CL:0002489!3.43e-09!2;CL:0000809!3.43e-09!2;CL:0000808!3.43e-09!2;CL:0000894!3.43e-09!2;CL:0000806!3.43e-09!2;CL:0000807!3.43e-09!2;CL:0000805!3.43e-09!2;CL:0002425!3.43e-09!2 | |||
|ontology_enrichment_celltype_v019=CL:0002127;9.37e-99;1!CL:0000911;9.37e-99;1!CL:0000814;9.37e-99;1!CL:0000084;4.64e-17;25!CL:0000542;3.56e-08;53!CL:0000791;7.18e-07;18!CL:0000789;7.18e-07;18!CL:0002419;7.18e-07;18 | |||
|ontology_enrichment_celltype_v019_2=CL:0002127,9.37e-99,1;CL:0000914,9.37e-99,1;CL:0000911,9.37e-99,1;CL:0000814,9.37e-99,1;CL:0002042,9.37e-99,1;CL:0002039,9.37e-99,1;CL:0002040,9.37e-99,1;CL:0002041,9.37e-99,1;CL:0000893,2.74e-50,2;CL:0002489,2.74e-50,2;CL:0000809,2.74e-50,2;CL:0000808,2.74e-50,2;CL:0000894,2.74e-50,2;CL:0000806,2.74e-50,2;CL:0000807,2.74e-50,2;CL:0000805,2.74e-50,2;CL:0002425,2.74e-50,2;CL:0000084,4.64e-17,25;CL:0000827,4.64e-17,25;CL:0000838,6.99e-09,52;CL:0000542,9.74e-09,53;CL:0000051,9.74e-09,53;CL:0000791,7.18e-07,18;CL:0000789,7.18e-07,18;CL:0002420,7.18e-07,18;CL:0002419,7.18e-07,18;CL:0000790,7.18e-07,18 | |||
|ontology_enrichment_development_v019=CL:0002425;2.74e-50;2!CL:0000051;3.56e-08;53!CL:0000790;7.18e-07;18 | |||
|ontology_enrichment_disease=DOID:2355!2.63e-16!1;DOID:74!8.09e-09!2 | |||
|ontology_enrichment_disease_v019=DOID:1036;1.07e-13;8!DOID:2531;1.57e-09;51!DOID:0060083;1.57e-09;51!DOID:1240;8.24e-08;39 | |||
|ontology_enrichment_disease_v019_2=DOID:1036,1.07e-13,8;DOID:1240,2.03e-11,39;DOID:2531,4.95e-09,51;DOID:0060083,4.95e-09,51 | |||
|ontology_enrichment_uberon=UBERON:0002146!1.41e-16!1;UBERON:0005623!1.41e-16!1;UBERON:0002370!2.85e-16!4;UBERON:0005058!2.85e-16!4;UBERON:0009113!2.85e-16!4;UBERON:0003295!2.85e-16!4;UBERON:0005562!2.85e-16!4;UBERON:0001042!2.33e-14!10;UBERON:0009145!2.33e-14!10;UBERON:0006562!4.11e-13!11;UBERON:0003351!3.57e-11!6;UBERON:0008814!8.92e-10!15;UBERON:0004177!1.04e-09!7;UBERON:0001871!1.31e-08!7;UBERON:0001557!7.81e-08!19;UBERON:0000974!4.66e-07!10;UBERON:0003408!4.66e-07!10 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002370,5.56e-26,4;UBERON:0005058,5.56e-26,4;UBERON:0009113,5.56e-26,4;UBERON:0003295,5.56e-26,4;UBERON:0005562,5.56e-26,4;UBERON:0003351,7.67e-18,6;UBERON:0004177,1.65e-15,7;UBERON:0005057,1.65e-15,7;UBERON:0000974,2.73e-11,10;UBERON:0003408,2.73e-11,10;UBERON:0001042,2.73e-11,10;UBERON:0009145,2.73e-11,10;UBERON:0006562,2.16e-10,11;UBERON:0009722,2.16e-10,11;UBERON:0007690,2.16e-10,11;UBERON:0008814,7.18e-07,18 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.242584061187816,0,0,0,0,0.256160706529101,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.128091319725675,0,0,0.276350017785848,0.289803085735052,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.48340575974109,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.02193298195737,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.30607276163049,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.229160424011684,0,0,0,0,0,0,0,0,0,0,0,0.0846733320657845,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.122026264901963,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0620747142958579,0,0,0,0.217716747896961,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr13:49078858..49078865,- | |||
}} |
Latest revision as of 16:32, 24 July 2015
Short description: | p@chr13:49078858..49078865, - |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr13:49078858..49078865, - |
Coexpression cluster: | C121_NK_Natural_CD8_CD4_anaplastic_chronic_B |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
innate effector T cell | 9.37e-99 | 1 |
immature NK T cell | 9.37e-99 | 1 |
effector T cell | 9.37e-99 | 1 |
mature NK T cell | 9.37e-99 | 1 |
immature NK T cell stage IV | 9.37e-99 | 1 |
immature NK T cell stage I | 9.37e-99 | 1 |
immature NK T cell stage II | 9.37e-99 | 1 |
immature NK T cell stage III | 9.37e-99 | 1 |
thymocyte | 2.74e-50 | 2 |
double negative thymocyte | 2.74e-50 | 2 |
double-positive, alpha-beta thymocyte | 2.74e-50 | 2 |
DN4 thymocyte | 2.74e-50 | 2 |
DN1 thymic pro-T cell | 2.74e-50 | 2 |
DN2 thymocyte | 2.74e-50 | 2 |
DN3 thymocyte | 2.74e-50 | 2 |
immature single positive thymocyte | 2.74e-50 | 2 |
early T lineage precursor | 2.74e-50 | 2 |
T cell | 4.64e-17 | 25 |
pro-T cell | 4.64e-17 | 25 |
lymphoid lineage restricted progenitor cell | 6.99e-09 | 52 |
lymphocyte | 9.74e-09 | 53 |
common lymphoid progenitor | 9.74e-09 | 53 |
mature alpha-beta T cell | 7.18e-07 | 18 |
alpha-beta T cell | 7.18e-07 | 18 |
immature T cell | 7.18e-07 | 18 |
mature T cell | 7.18e-07 | 18 |
immature alpha-beta T cell | 7.18e-07 | 18 |
Ontology term | p-value | n |
---|---|---|
thymus | 5.56e-26 | 4 |
hemolymphoid system gland | 5.56e-26 | 4 |
thymic region | 5.56e-26 | 4 |
pharyngeal gland | 5.56e-26 | 4 |
thymus primordium | 5.56e-26 | 4 |
pharyngeal epithelium | 7.67e-18 | 6 |
hemopoietic organ | 1.65e-15 | 7 |
immune organ | 1.65e-15 | 7 |
neck | 2.73e-11 | 10 |
gland of gut | 2.73e-11 | 10 |
chordate pharynx | 2.73e-11 | 10 |
pharyngeal region of foregut | 2.73e-11 | 10 |
pharynx | 2.16e-10 | 11 |
entire pharyngeal arch endoderm | 2.16e-10 | 11 |
early pharyngeal endoderm | 2.16e-10 | 11 |
pharyngeal arch system | 7.18e-07 | 18 |
Ontology term | p-value | n |
---|---|---|
chronic leukemia | 1.07e-13 | 8 |
leukemia | 2.03e-11 | 39 |
hematologic cancer | 4.95e-09 | 51 |
immune system cancer | 4.95e-09 | 51 |